HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiro Tanaka Selected Research

sorbitan monooleate (Span 80)

7/2008Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis.
3/2008Induction of apoptosis of human tumor cells by hybrid liposomes including docosahexaenoic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiro Tanaka Research Topics

Disease

62Neoplasms (Cancer)
04/2022 - 01/2004
17Esophageal Neoplasms (Esophageal Cancer)
05/2022 - 02/2016
17Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2010
15Neoplasm Metastasis (Metastasis)
03/2022 - 01/2010
15Stomach Neoplasms (Stomach Cancer)
12/2020 - 06/2008
13Hemorrhage
05/2022 - 10/2008
8Esophageal Squamous Cell Carcinoma
04/2022 - 11/2010
8Major Depressive Disorder (Major Depressive Disorders)
10/2015 - 01/2007
8Panic Disorder (Panic Attack)
01/2015 - 02/2007
7Rectal Neoplasms (Rectal Cancer)
02/2022 - 01/2010
6Lymphatic Metastasis
04/2022 - 11/2017
6Colonic Neoplasms (Colon Cancer)
01/2021 - 05/2008
6Carcinoma (Carcinomatosis)
12/2011 - 12/2006
4Acute Coronary Syndrome
05/2022 - 07/2018
4Necrosis
04/2022 - 01/2013
4Abdominal Pain (Pain, Abdominal)
04/2022 - 01/2015
4Stomatitis
01/2022 - 02/2016
4Rupture
07/2020 - 05/2017
4Aneurysm (Aneurysms)
05/2019 - 05/2011
4Ovarian Neoplasms (Ovarian Cancer)
05/2009 - 08/2004
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2022 - 01/2008
3Thrombosis (Thrombus)
03/2022 - 06/2021
3Fever (Fevers)
03/2022 - 01/2010
3Infections
01/2022 - 05/2009
3Atrial Fibrillation
01/2022 - 01/2018
3Adenocarcinoma
10/2021 - 01/2012
3Peripheral Arterial Disease
10/2020 - 09/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 12/2006
3Ischemia
01/2018 - 12/2007
3Breast Neoplasms (Breast Cancer)
01/2018 - 04/2010
3Cardiovascular Diseases (Cardiovascular Disease)
11/2017 - 09/2005
3Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2014 - 01/2012
3Wounds and Injuries (Trauma)
01/2012 - 01/2010
2Pancreatic Fistula (Pancreatic Fistulas)
07/2022 - 01/2012
2Cardiac Tamponade
05/2022 - 11/2019
2Fistula
04/2022 - 07/2020
2Carcinogenesis
01/2022 - 01/2012
2Glioma (Gliomas)
01/2022 - 01/2015
2Shock
01/2022 - 08/2012
2Venous Thromboembolism
11/2021 - 05/2019
2Chylothorax
08/2021 - 04/2020
2Abscess
04/2021 - 07/2020
2Pathologic Constriction (Stenosis)
11/2020 - 03/2018
2Vomiting
05/2020 - 12/2017
2Pleural Effusion (Pleural Effusions)
04/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

9Cisplatin (Platino)FDA LinkGeneric
04/2022 - 12/2006
9Docetaxel (Taxotere)FDA Link
04/2022 - 12/2006
9Hydrocortisone (Cortisol)FDA LinkGeneric
01/2016 - 01/2007
8Fluorouracil (Carac)FDA LinkGeneric
04/2022 - 11/2010
7Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2004
5Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2012
4Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 01/2015
3AnticoagulantsIBA
03/2022 - 12/2020
3AntigensIBA
11/2020 - 01/2016
3Monoclonal AntibodiesIBA
10/2019 - 02/2014
3Bevacizumab (Avastin)FDA Link
10/2019 - 12/2016
3Cetuximab (Erbitux)FDA Link
06/2019 - 01/2018
3ErbB Receptors (EGF Receptor)IBA
05/2018 - 08/2004
3Glutamine (L-Glutamine)FDA Link
05/2016 - 02/2016
3Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2014 - 01/2012
3ChitosanIBA
09/2013 - 01/2010
3HydrogelsIBA
09/2013 - 01/2010
3Salivary alpha-AmylasesIBA
08/2013 - 03/2012
3GhrelinIBA
01/2012 - 10/2008
3Phosphotransferases (Kinase)IBA
01/2012 - 08/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2011 - 08/2004
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2010 - 12/2007
3Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
07/2005 - 08/2004
2Indicators and Reagents (Reagents)IBA
04/2022 - 11/2019
2SteroidsIBA
02/2022 - 11/2020
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2021
2CholesterolIBA
09/2021 - 07/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 10/2019
2Pharmaceutical PreparationsIBA
12/2020 - 10/2016
2NivolumabIBA
12/2020 - 10/2018
2Leucovorin (Folinic Acid)FDA Link
11/2020 - 08/2019
2TegafurIBA
11/2020 - 08/2019
2UracilIBA
11/2020 - 08/2019

Therapy/Procedure

43Therapeutics
01/2022 - 08/2004
39Drug Therapy (Chemotherapy)
04/2022 - 12/2006
11Esophagectomy
05/2022 - 05/2019
9Neoadjuvant Therapy
01/2022 - 01/2012
7Lymph Node Excision (Lymph Node Dissection)
05/2022 - 05/2013
5Stents
11/2019 - 12/2014
5Hepatectomy
10/2015 - 01/2010
4Radiotherapy
01/2022 - 01/2010
4Adjuvant Chemotherapy
12/2021 - 02/2018
4Conservative Treatment
05/2020 - 01/2018
4Gastrectomy
11/2017 - 06/2013
3Percutaneous Coronary Intervention
05/2022 - 08/2019
3Thoracotomy
04/2022 - 12/2021
3Aftercare (After-Treatment)
04/2022 - 01/2014
3Minimally Invasive Surgical Procedures
02/2021 - 01/2011
3Immunotherapy
01/2018 - 11/2010
2Ligation
05/2022 - 05/2011
2Length of Stay
01/2022 - 11/2013
2Chemoradiotherapy
12/2021 - 01/2010
2Operative Surgical Procedures
11/2020 - 10/2015
2Enteral Nutrition (Feeding, Tube)
07/2020 - 04/2020
2Ileostomy
01/2020 - 09/2018